About
HUINNO, founded in 2014, is a 500 Startups and venture-backed digital healthcare company with offices in Boston, New York, and Seoul. They are focusing on changing the way clinicians and patients manage chronic cardiac diseases using their proprietary breakthrough technologies in wearable devices and AI-based analytics cloud. HUINNO's clinically-tested platform is capable of continuously measuring a variety of vital health data in real-time with clinical-grade accuracy. -- By combining wrist and chest wearables with artificial intelligence, HUINNO provides superior real-time cardiac biometrics including ECG, Blood Pressure, Heart Rate, SpO2. Delivering healthcare providers with an effective remote patient monitoring solution that drastically improves chronic cardiac disease prevention while lowering readmission rate compared to the existing standard of care. HUINNO's app and cloud-based eco-system also allow consumers to access longitudinal trend analysis of blood pressure, medica
Position in the VCSift Database
- • 1,256 investors in VCSift focus on the ai-ml sector.
- • 1,203 investors are based in Seoul, Seoul-t'ukpyolsi, South Korea.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- ai-ml healthtech saas
- Location
- Seoul, South Korea
Contact Information
Find more investors like HUINNO
Search Investors